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Open access under CC BY-NC-ND license.Are Hedgehog and Wnt/b-catenin pathways involved in
hepatitis C virus-mediated EMT?To the Editor:
We read with great interest the article by Akkari et al. [1], who
evaluated the EMT induction and correlated oncogenic transfor-
mation induced by HCV protein NS5A in primary hepatocyte
precursors.
Epithelial–mesenchymal transition (EMT) is a biological pro-
cess occurring during tissue development and regeneration,
moreover, it is known to be involved in tumor progression and
metastasis. The EMT is a phenomenon, which well represents
the cellular plasticity, i.e., the ability of polarized epithelial cells,
which through multiple biochemical changes acquire a mesen-
chymal cell phenotype. These cells exhibit loss of cell adhesion,
enhanced migratory capacity, invasiveness, elevated resistance
to apoptosis and a great ability to produce extracellular matrix
(ECM) components. Several molecular processes are involved in
EMT onset and progression. Among them we have to mention:
activation of transcription factors (e.g., Snail, Twist, etc.), expres-
sion of speciﬁc cell-surface proteins, remodelling of cytoskeletal
components, production of ECM-degrading enzymes and changes
in the expression of speciﬁc microRNAs (e.g., microRNA 200 fam-
ily). Most of them are commonly used as biomarkers to highlight
a cellular EMT [2,3].
Akkari et al. have evaluated how a viral protein can alter the
typical epithelial architecture of hepatic cells. In particular, they
demonstrated that the ectopic expression of hepatitis C virus
(HCV) non-structural protein 5a (NS5A) is able to induce EMT
in bipotential mouse embryonic liver (BMEL) cells which acquire
mesenchymal phenotype, increased motility and invasiveness,
and are featured by the downregulation of epithelial markers
(e.g., E-Cadherin) and the upregulation of mesenchymal markers
(like Vimentin and Twist2). They also conﬁrmed their results in
an in vivo xenograft mouse model.
To unravel the molecular mechanisms involved in EMT occur-
rence, they focused their experimental investigation on trans-
forming growth factor (TGF)-b, a main cytokine involved in
EMT induction. They have shown that NS5A is not responsible
for TGF-b pathway activation but it acts in a synergistic manner
with the cytokine in inducing EMT. Furthermore, they also
screened, in their in vitro model, the modulation of expression
of EMT biomarkers, such as Snail, Slug, Zeb and Twist 1/2. They
demonstrated that only Twist2 expression was speciﬁcally
increased by NS5A protein, and that, accordingly, through short
hairpin RNA against Twist2, they were able to counteract EMT
occurrence. Interestingly, the TGF-b treatment of cells lacking of
Twist2 is able to promote EMT in any case, suggesting that
NS5A and TGF-b trigger EMT by distinct pathways and thus
identifying Twist2 as an NS5A EMT speciﬁc effector.Journal of Hepatology 20Unfortunately, as the authors stated in the discussion ses-
sion, currently the mechanisms underlying Twist2 involvement
in NS5A-dependent and TGF-b-independent EMT are not yet
known.
Regarding the HCV context, it is well known that NS5A activ-
ities are strictly connected to many cellular proteins and have an
impact on several signaling pathways like, for instance, the
hedgehog (HH) pathway [4]. This correlation is really interesting,
because the HH pathway has emerged as an important mediator
of liver cancer pathogenesis [5]. Recently, this pathway was
involved in the reprogramming of cancer cells via EMT. In fact,
the upregulation of HH was associated with increased cell motil-
ity, invasion and tumor cell aggressiveness [5].
It is interesting to underline that different liver cell lines, such
as HuH 7.5 and LH86, which are featured by high expression lev-
els of HH pathway genes (e.g., sonic hedgehog (SHH), glioblas-
toma protein 1 (Gli1), and patched (PTC)), are the most diffuse
cells supporting a high HCV replication rate. It was also demon-
strated that the upregulation of mesenchymal markers and the
downregulation of epithelial markers were deeply connected to
HH signaling [4].
Besides the intracellular pathways governed by HH, Wnt/b-
catenin pathway is known to have a role in EMT induction [3].
This pathway could be strikingly relevant, because it is also
involved in HCV-related neoplastic transformation and EMT
onset [6,7].
The authors suggest that the mechanism underlying EMT
caused by HCV is reallymore intricate andmay involve a lot of sig-
naling pathways, like HH and Wnt/b-catenin, which are already
known to be involved in organogenesis and cell transformation.
Our preliminary data obtained through the use of an in vitro
model of HCV infection, such as HuH 7.5 cells infected with the
full length chimeric HCV strain J6/JFH1, at 48 h after infection
indicate a signiﬁcant upregulation of the EMT marker gene,
Twist1 (fold change: 16.55 ± 0.20) and several molecules involved
in Wnt/b-catenin pathway such as: Wnt5a (fold change:
5.32 ± 0.32), Wnt5b (fold change: 3.60 ± 0.11), and LRP5 (fold
change: 5.12 ± 0.15). Taken into account the high expression lev-
els of HH pathway components in our cell model, our results sug-
gest that during HCV infection with a complete viral strain, other
genes involved in the EMT induction, i.e., Twist1, may be
upregulated.
In conclusion, a deep investigation of the intricate molecular
pathways modulated by HCV should be considered in order to
improve the existent know-how and to identify new potential
therapeutic targets useful to develop innovative and effective tar-
geted therapies against the HCV-related liver diseases.13 vol. 58 j 634–640
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is not involved in EMT mediated by HCV NS5A protein
To the Editor:
We thank Conti et al. for the interesting discussion of our recent
paper. We agree that it is of major interest to delineate the
molecular mechanisms leading from HCV protein NS5A to Twist2
induction, which we have shown to trigger EMT in hepatocytes.
Several plausible effectors of NS5A could be involved in this pro-
cess, including the Wnt/b-catenin and the Hedgehog (HH)
pathways.
Interestingly, at least three different HCV proteins have been
reported to trigger EMT in hepatocytes: some isotypes of core
[1], E1/E2 [2] and, as reported by us, NS5A [3]. While the end
results of these processes appear quite similar, the different viral
proteins employ distinct mechanisms of EMT induction, with the
notable involvement of TGF-b signalling for the core and enve-
lope proteins but not for NS5A-mediated EMT. Moreover, they
probably operate with different kinetics following their expres-
sion (discussed in [3]). The very fact that HCV has evolved several
mechanisms to trigger EMT strongly suggests that the process is
important for viral physiology and/or spread. It also means that
the mechanisms ascribed to NS5A-mediated induction of EMT
are expected to be present in experimental models that include
the whole complement of viral proteins, while the reverse is
not necessarily true. Following this line of argument, we note that
the increased level of expression of the components of the Hedge-
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hog pathway and their impact on HCV replication were observed
in the model based on JFH1 infection of HuH7.5 cells [4]. We have
obtained comparable results in the infection of human primary
hepatocytes (PHH) (Fig. 1A), thus conﬁrming the results of Choi
et al. in this experimental setting. To our knowledge, there are
no reports of effects of NS5A on HH expression or signalling.
Our data suggest that increased synthesis of components of the
Hedgehog pathway is not required for NS5A-mediated EMT, since
expression of Sonic Hedgehog, Gli1 or Patched is not altered in
cells that undergo this process under the inﬂuence of NS5A [3],
the BMEL-NS5A (Fig. 1B).
The situation is a little different for the Wnt/b-catenin path-
way. NS5A activates b-catenin signalling through interactions
with the catalytic subunit of PI(3)K [5] or directly [6], leading
in both cases to accumulation and nuclear translocation of b-
catenin and transcription of its target genes, such as axin2, gluta-
mine synthase or c-myc. This scheme has recently been elegantly
conﬁrmed in several cellular and in vivo contexts by Higgs and
colleagues [7]. In addition to this non-transcriptional regulation
of b-catenin signalling, HCV core protein has been reported to
induce transcription of several Wnt ligands, their receptors
(Frizzled) and co-receptors (LRP5) in hepatoma cells [8,9]. In con-
trast to these reports and the interesting data of Conti et al., we
see no long-term alteration of wnt5 expression in the JFH1-
infected PHH. Interestingly, expression of LRP5 is high in these
cells and transcription of axin2, one of b-catenin target genes, is
increased. These results suggest that the pathway is persistently
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